K. V. Viana-Cardoso, M. T. B. Silva, A. A. Peixoto-Junior, L. S. Marinho, N. S. Matias, P. M. G. Soares, A. A. Santos, G. A. C. Brito, F. H. Rola, F. de A. A. Gondim
{"title":"Sensory and inflammatory colonic changes induced by vincristine in distinct rat models of colitis","authors":"K. V. Viana-Cardoso, M. T. B. Silva, A. A. Peixoto-Junior, L. S. Marinho, N. S. Matias, P. M. G. Soares, A. A. Santos, G. A. C. Brito, F. H. Rola, F. de A. A. Gondim","doi":"10.1111/aap.12020","DOIUrl":"10.1111/aap.12020","url":null,"abstract":"<div>\u0000 \u0000 <p>Preclinical and clinical studies show that gastrointestinal (GI) inflammation can evoke sensory changes occasionally far from the original inflammatory site. Animal models of colitis with either trinitrobenzenesulphonic acid (TNBS) or mustard oil (MO) produce distinct patterns of somatic and visceral sensory changes. We evaluated the effects of four doses of i.v. vincristine 150 μg kg<sup>−1</sup> (total of 600 μg kg<sup>−1</sup>) treatment on the somatic (thermal nociceptive threshold) and colonic (morphological) changes induced by TNBS or MO in rats. TNBS and MO groups were further submitted to vincristine or saline pretreatments. TNBS induced somatic hypersensitivity, while MO induced somatic hyposensitivity (<i>P</i> < 0.05) when compared to the saline and ethanol control groups. Vincristine <i>per se</i> induced somatic hypersensitivity (<i>P</i> < 0.05). This effect was enhanced by TNBS and reversed by MO treatments. Although vincristine increased the colitis area (colonic weight length<sup>−1</sup> ratio) and the Morris' score in TNBS-treated rats, it did not alter the colitis area and even lowered the Morris' score in MO-treated rats. Compared to the saline (control) group, vincristine did not alter the colonic microscopic pattern. However, such lesions scores are higher (<i>P</i> < 0.05) in colitis groups induced by TNBS and MO, pretreated or not with vincristine. In conclusion, the somatic changes induced by different models of experimental colitis are diverse and modulated differently by vincristine.</p>\u0000 </div>","PeriodicalId":100151,"journal":{"name":"Autonomic and Autacoid Pharmacology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2015-02-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1111/aap.12020","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"33073758","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Noradrenaline transmission reducing drugs may protect against a broad range of diseases.","authors":"P. J. Fitzgerald","doi":"10.1111/aap.12019","DOIUrl":"10.1111/aap.12019","url":null,"abstract":"<div>\u0000 \u0000 <p><b>1</b> A growing body of evidence suggests that the signalling molecule, noradrenaline (NA), plays a pathophysiological role in a broad range of psychiatric, neurological and peripheral disorders. Both preclinical and clinical data suggest that elevated NA signalling may be involved in the aetiology of major diseases such as depression, Alzheimer's disease and diabetes mellitus. <b>2</b> The molecular pathways by which NA may cause the manifestation of disease remain poorly understood, although they may include G protein-coupled receptor modulation of the Ras/MAP kinase, Stat3 and PI3K pathways, among others. In both individual animals and humans, NA tone may be elevated largely due to genetics, but also because of the exposure to marked psychological stress or trauma, or other environmental factors. <b>3</b> As NA is involved in the ‘fight or flight’ response by the sympathetic nervous system, this transmitter may be elevated in a large number of organisms due to evolutionary selection of enhancing responses to immediate environmental dangers. Likewise, acetylcholine signalling by the parasympathetic (‘rest and digest’) nervous system may be relatively diminished. This putative autonomic imbalance may result in diminished engagement in homeostatic processes, resulting in the emergence and progression of a number of diseases throughout the body. <b>4</b> In this scenario, a large number of individuals may benefit from chronic use of pharmacological agents – such as clonidine, guanfacine, propranolol or prazosin – that diminish NA signalling throughout the body. If so, NA transmission lowering drugs may protect against a wide range of diseases.</p>\u0000 </div>","PeriodicalId":100151,"journal":{"name":"Autonomic and Autacoid Pharmacology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2014-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1111/aap.12019","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"32710210","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
F. Rezania, L. Mohaghegh Shalmani, R. Rahimian, A. R. Dehpour, S. Ejtemaei Mehr
{"title":"Pretreatment with clonidine caused desensitization to WIN 55,212-2 in guinea pig ileum","authors":"F. Rezania, L. Mohaghegh Shalmani, R. Rahimian, A. R. Dehpour, S. Ejtemaei Mehr","doi":"10.1111/aap.12018","DOIUrl":"10.1111/aap.12018","url":null,"abstract":"<div>\u0000 \u0000 <p>\u0000 \u0000 </p><ol>\u0000 \u0000 \u0000 <li>Considering the existence of cross-tolerance between clonidine and morphine besides the same interaction between morphine and WIN 55,212-2 persuaded us to verify this fact between WIN 55,212-2 and clonidine in guinea pig ileum, which is a well-known model to examine the mode of action of cannabinoids and α<sub>2</sub>-adenoceptor agonists</li>\u0000 \u0000 \u0000 <li>The rectangular pulses were passed to the 0.5 g stretched ileum segments that were fixed in 20-ml organ bath. PowerLab system and Graphpad Prism were applied to record twitches and analyse the data. Electrically evoked contractions were dose-dependently inhibited by WIN 55,212-2 and clonidine (p<i>D</i><sub><i>2</i></sub>= 8.56 ± 0.41 and 7.65 ± 0.15, respectively).</li>\u0000 \u0000 \u0000 <li>Tolerance to this effect could be induced by 4-h incubation with WIN 55,212-2 (3 × IC<sub>50</sub>) (<i>p</i>D<sub>2</sub> = 6.36 ± 0.26, degree of tolerance: 159.32) (<i>P </i><<i> </i>0.01) but not with clonidine (2 × IC<sub>50</sub> and 4 × IC<sub>50</sub>) for different time courses. Dose–response curve for inhibitory action of WIN 55,212-2 was shifted to the right after 4-h incubation with clonidine (3 × 10<sup>−10</sup><span>m</span>) comparing to the untreated tissues (<i>p</i>D<sub>2</sub> = 5.26 ± 0.69, degree of tolerance: 2000) (<i>P </i><<i> </i>0.001). This observation provides the evidence for the cannabinoid-noradrenergic systems interaction in the enteric nervous system as a simplified representative for central nervous system.</li>\u0000 </ol>\u0000 \u0000 </div>","PeriodicalId":100151,"journal":{"name":"Autonomic and Autacoid Pharmacology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2014-03-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1111/aap.12018","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"32212869","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
E. H. Juárez, F. Ochoa-Cortés, M. Miranda-Morales, R. Espinosa-Luna, L. M. Montaño, C. Barajas-López
{"title":"Selectivity of antagonists for the Cys-loop native receptors for ACh, 5-HT and GABA in guinea-pig myenteric neurons","authors":"E. H. Juárez, F. Ochoa-Cortés, M. Miranda-Morales, R. Espinosa-Luna, L. M. Montaño, C. Barajas-López","doi":"10.1111/aap.12016","DOIUrl":"10.1111/aap.12016","url":null,"abstract":"<div>\u0000 \u0000 <p>\u0000 \u0000 </p><ol>\u0000 \u0000 \u0000 <li>The three most common <i>Cys-loop</i> receptors expressed by myenteric neurons are nACh, 5-HT<sub>3</sub> and GABA<sub>A</sub>. To investigate the function of these proteins researchers have used channel inhibitors such as hexamethonium (antagonist of nACh receptors), ondansetron (antagonist of 5-HT<sub>3</sub> receptors), picrotoxin and bicuculline (both antagonists of GABA<sub>A</sub> receptors). The aim of this study was to investigate the specificity of these inhibitors on <i>Cys-loop</i> receptors of primary cultured neurons obtained from the guinea-pig small intestine. The whole-cell configuration of the patch clamp techniques was used to record membrane currents induced by ACh (I<sub>ACh</sub>), 5-HT (I<sub>5-HT</sub>) and GABA (I<sub>GABA</sub>) in the absence and the presence of various concentrations of hexamethonium, ondansetron, picrotoxin or bicuculline.</li>\u0000 \u0000 \u0000 <li>The three <i>Cys-loop</i> receptors present in enteric neurons are expressed independently and they do not cross-desensitized. Hexamethonium inhibited I<sub>ACh</sub> without affecting I<sub>5-HT</sub> and I<sub>GABA</sub>. Ondansetron inhibited I<sub>5-HT</sub> and also I<sub>ACh</sub> but did not affect I<sub>GABA</sub>. Picrotoxin and bicuculline inhibited I<sub>5-HT</sub>, I<sub>ACh</sub> and I<sub>GABA</sub> with different potency, being the lowest potency on 5-HT<sub>3</sub> receptors. All these inhibitory effects were concentration dependent and reversible.</li>\u0000 \u0000 \u0000 <li>Our observations showed that except for hexamethonium, all other inhibitors used here show different degrees of selectivity, which has to be considered when these antagonists are used in experimental studies aimed to investigate the functions of these receptors. In particular, in tissues expressing nACh receptors because these are the targets of all other inhibitors used here. The low potency of picrotoxin and bicuculline to inhibit 5-HT<sub>3</sub> receptors suggests that these receptors are heteromeric proteins.</li>\u0000 </ol>\u0000 \u0000 </div>","PeriodicalId":100151,"journal":{"name":"Autonomic and Autacoid Pharmacology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2013-10-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1111/aap.12016","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40258191","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Prazosin has low potency at α1A-adrenoceptors and high potency at α1D-adrenoceptors in rat vas deferens","authors":"J. R. Docherty","doi":"10.1111/aap.12015","DOIUrl":"10.1111/aap.12015","url":null,"abstract":"<div>\u0000 \u0000 <p>\u0000 \u0000 </p><ol>\u0000 \u0000 \u0000 <li>We have investigated α<sub>1</sub>-adrenoceptor subtypes mediating contractions to noradrenaline in epididymal portions of rat vas deferens.</li>\u0000 \u0000 \u0000 <li>Contractions to noradrenaline were investigated in the absence or presence of the noradrenaline transporter blocker cocaine.</li>\u0000 \u0000 \u0000 <li>In the absence of cocaine, contractions to noradrenaline were potently antagonized by RS100329, but not by BMY7378, and so are mediated mainly by α<sub>1A</sub>-adrenoceptors.</li>\u0000 \u0000 \u0000 <li>In the presence of cocaine, noradrenaline potency was increased, particularly in terms of low concentrations and phasic contractions. Contractions to low concentrations of noradrenaline in the presence of cocaine were resistant to RS100329 but potently antagonized by BMY7378, demonstrating that α<sub>1D</sub>-adrenoceptors are additionally involved in contractions amplified by cocaine.</li>\u0000 \u0000 \u0000 <li>In the absence of cocaine, prazosin exhibited relatively low potency as an antagonist against the α<sub>1A</sub>-adrenoceptor-mediated component to the response. In the presence of cocaine, prazosin exhibited higher potency against the α<sub>1D</sub>-adrenoceptor-mediated component.</li>\u0000 \u0000 \u0000 <li>In conclusion, prazosin has previously unreported selectivity for α<sub>1D</sub>- over α<sub>1A</sub>-adrenoceptors in functional studies of rat vas deferens. Contractions of rat vas deferens are mediated by α<sub>1A</sub>- and α<sub>1D</sub>-adrenoceptors. The range of prazosin potencies and of receptor subtypes previously reported in rat vas deferens may be explained by the presence of these two subtypes.</li>\u0000 </ol>\u0000 \u0000 </div>","PeriodicalId":100151,"journal":{"name":"Autonomic and Autacoid Pharmacology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2013-09-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1111/aap.12015","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"31764520","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
H. A. Peredo, V. Andrade, A. S. Donoso, H. J. Lee, A. M. Puyó
{"title":"Sodium molybdate prevents hypertension and vascular prostanoid imbalance in fructose-overloaded rats","authors":"H. A. Peredo, V. Andrade, A. S. Donoso, H. J. Lee, A. M. Puyó","doi":"10.1111/aap.12010","DOIUrl":"10.1111/aap.12010","url":null,"abstract":"<div>\u0000 \u0000 <p>\u0000 \u0000 </p><ol>\u0000 \u0000 <li>Fructose (F) overload produces elevated blood pressure (BP), hyperglycaemia, hypertriglyceridemia and insulin resistance, resembling human metabolic syndrome. Previously, we found altered vascular prostanoid (PR) production in this model.</li>\u0000 \u0000 <li>Sodium molybdate (Mo), as well as sodium tungstate, causes insulin-like effects and normalizes plasma glucose levels in streptozotocin-treated diabetic rats. We studied the effects of Mo on BP, metabolic parameters and release of PR from the mesenteric vascular bed (MVB) in F-overloaded rats.</li>\u0000 \u0000 <li>Four groups of male Sprague-Dawley rats were analysed: Control, tap water to drink; F, F solution 10% W/V to drink; CMo, Mo 100 mg kg day<sup>−1</sup> and FMo, both treatments. After 9 weeks, the animals were killed and MVBs removed and the released PRs measured.</li>\u0000 \u0000 <li>F increased BP, glycemia, triglyceridemia and insulinemia. Mo treatment prevented the increases in BP and glycemia, but did not modify triglyceridemia or insulinemia. In addition, Mo decreased BP in controls.</li>\u0000 \u0000 <li>Prostaglandins (PG) F<sub>2</sub>alpha and E<sub>2,</sub> PG 6-ketoF<sub>1</sub>alpha and thromboxane (TX) B<sub>2</sub>, as well as inactive metabolites of prostacyclin (PGI<sub>2</sub>) and TXA<sub>2</sub> were detected. F decreased the production of vasodilator PRs PGI<sub>2</sub> and PGE<sub>2</sub> in MVB. Mo prevented these alterations and increased PGE<sub>2</sub> in controls. Vasoconstrict or PRs PGF<sub>2</sub>alpha and TXA<sub>2</sub> release was not modified.</li>\u0000 \u0000 <li>Mo treatment, beyond its known lowering effect on glycemia, prevents the reduction in the vascular release of vasodilator PR observed in this model. This could be one of the mechanisms by which Mo avoids the increase in BP caused by F overload in the rat.</li>\u0000 </ol>\u0000 \u0000 </div>","PeriodicalId":100151,"journal":{"name":"Autonomic and Autacoid Pharmacology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2013-08-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1111/aap.12010","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"31265907","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Influence of ketanserin on the effects of methylenedioxymethamphetamine on body temperature in the mouse","authors":"J. R. Docherty, S. Bexis","doi":"10.1111/aap.12009","DOIUrl":"10.1111/aap.12009","url":null,"abstract":"<div>\u0000 \u0000 <p>\u0000 \u0000 </p><ol>\u0000 \u0000 \u0000 <li>We have investigated the ability of the 5HT<sub>2</sub>-receptor antagonist ketanserin to affect the hyperthermia produced by methylenedioxymethamphetamine (MDMA) in conscious mice and examined whether α<sub>1</sub>-adrenoceptor antagonist actions are involved.</li>\u0000 \u0000 \u0000 <li>Mice were implanted with intra-abdominal temperature probes under anaesthesia and allowed 2 weeks recovery. MDMA (20 mg kg<sup>−1</sup>) was administered subcutaneously 30 min after vehicle or test antagonist and effects on body temperature monitored by telemetry.</li>\u0000 \u0000 \u0000 <li>Following vehicle, MDMA produced a slowly developing hyperthermia, reaching a maximum increase of 1.24 °C at 150 min postinjection. Ketanserin (0.5 mg kg<sup>−1</sup>) revealed a significant and marked early hypothermia to MDMA, an effect that is mimicked by the α<sub>1</sub>-adrenoceptor antagonist prazosin (0.1 mg kg<sup>−1</sup>).</li>\u0000 \u0000 \u0000 <li>Functional studies revealed antagonist actions of ketanserin at α<sub>1</sub>-adrenoceptors in rat aorta and rat vas deferens <i>in vitro</i> indicative of α<sub>1</sub>-adrenoceptor antagonist actions at the concentration used <i>in vivo</i>.</li>\u0000 \u0000 \u0000 <li>In conclusion, ketanserin (0.5 mg kg<sup>−1</sup>) modulates the hyperthermic actions of MDMA in mice. Although we cannot rule out additional actions at 5HT<sub>2</sub>-receptors, the actions of ketanserin are consistent with α<sub>1</sub>-adrenoceptor antagonism. There is no clear evidence from this study that 5HT<sub>2</sub>-receptors mediate the hyperthermic response to MDMA.</li>\u0000 </ol>\u0000 \u0000 </div>","PeriodicalId":100151,"journal":{"name":"Autonomic and Autacoid Pharmacology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2013-08-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1111/aap.12009","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"31625013","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Topical anaesthesia does not affect cutaneous vasomotor or sudomotor responses in human skin","authors":"K. Metzler-Wilson, T. E. Wilson","doi":"10.1111/aap.12007","DOIUrl":"10.1111/aap.12007","url":null,"abstract":"<div>\u0000 \u0000 <p>\u0000 \u0000 </p><ol>\u0000 \u0000 \u0000 <li>The effects of local sensory blockade (topical anaesthesia) on eccrine sweat glands and cutaneous circulation are not well understood. This study aimed to determine whether topical lidocaine/prilocaine alters eccrine sweat gland and cutaneous blood vessel responses.</li>\u0000 \u0000 \u0000 <li>Sweating (capacitance hygrometry) was induced via forearm intradermal microdialysis of five acetylcholine (ACh) doses (1 × 10<sup>−4</sup> to 1 × 10<sup>0</sup> <span>m</span>, 10-fold increments) in control and treated forearm sites in six healthy subjects. Nitric oxide-mediated vasodilatory (sodium nitroprusside) and adrenergic vasoconstrictor (noradrenaline) agonists were iontophoresed in lidocaine/prilocaine-treated and control forearm skin in nine healthy subjects during blood flow assessment (laser Doppler flowmetry, expressed as% from baseline cutaneous vascular conductance; CVC; flux/mean arterial pressure).</li>\u0000 \u0000 \u0000 <li>Non-linear regression curve fitting identified no change in the ED<sub>50</sub> of ACh-induced sweating after sensory blockade (−1.42 ± 0.23 logM) compared to control (−1.27 ± 0.23 logM; <i>P</i> > .05) or in <i>E</i><sub>max</sub> (0.43 ± 0.08 with, 0.53 ± 0.16 mg cm<sup>−2</sup> min<sup>−1</sup> without lidocaine/prilocaine; <i>P</i> > .05). Sensory blockade did not alter the vasodilator response to sodium nitroprusside (1280 ± 548% change from baseline CVC with, 1204 ± 247% without lidocaine/prilocaine) or vasoconstrictor response to noradrenaline (−14 ± 4% change from baseline CVC with, −22 ± 14% without lidocaine/prilocaine; <i>P</i> > 0.05).</li>\u0000 \u0000 \u0000 <li>Cutaneous sensory blockade does not appear to alter nitric oxide-mediated vasodilation, adrenergic vasoconstriction, or cholinergic eccrine sweating dose-response sensitivity or responsiveness to maximal dose. Thus, lidocaine/prilocaine treatment should not affect sweat gland function or have blood flow implications for subsequent research protocols or clinical procedures.</li>\u0000 </ol>\u0000 \u0000 </div>","PeriodicalId":100151,"journal":{"name":"Autonomic and Autacoid Pharmacology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2013-05-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1111/aap.12007","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"31421294","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
J. C. Patel, M. J. Barvaliya, T. K. Patel, C. B. Tripathi
{"title":"Neuromuscular blocking effect of fluoxetine and its interaction with rocuronium","authors":"J. C. Patel, M. J. Barvaliya, T. K. Patel, C. B. Tripathi","doi":"10.1111/aap.12005","DOIUrl":"10.1111/aap.12005","url":null,"abstract":"<div>\u0000 \u0000 <p>\u0000 \u0000 </p><ol>\u0000 \u0000 <li>As selective serotonin reuptake inhibitors have an inhibitory effect on nicotinic acetylcholine receptors, they may affect the neuromuscular transmission and interact with neuromuscular blockers. This study was designed to observe the effect of fluoxetine on neuromuscular transmission and its interaction with rocuronium using the rat phrenic nerve hemidiaphragm and rabbit head drop methods.</li>\u0000 \u0000 <li>Rat phrenic nerve hemidiaphragms were mounted and stimulated using a train of four pulses (TOF). The effect of fluoxetine was studied on both indirectly and directly stimulated basal twitch responses by plotting cumulative dose response curves (DRCs). DRCs of rocuronium were obtained in the absence, and presence of 5 μ<span>m</span> and 20 μ<span>m</span> fluoxetine to study its interaction. ED<sub>5</sub>, ED<sub>50</sub> and ED<sub>95</sub> values of rocuronium DRCs in absence and presence of fluoxetine were calculated.</li>\u0000 \u0000 <li>Fluoxetine significantly inhibited twitch responses in both indirect and directly stimulated preparations. Fluoxetine (20 μ<span>m</span>) caused an increase in the potency of rocuronium such that the ED<sub>50</sub> and ED<sub>95</sub> values of rocuronium DRCs were significantly decreased. Partially inhibited twitch responses by fluoxetine (100 μ<span>m</span>) were not reversed by neostigmine (3.3 μ<span>m</span>) or 3,4 diaminopyridine (0.25 μ<span>m</span>).</li>\u0000 \u0000 <li>Rabbits were given fluoxetine 0.25 mg kg<sup>−1</sup> and 1 mg kg<sup>−1</sup> orally for 15 days, and on 15th day, rocuronium infusion was given, and time for head drop was recorded. The time of head drop was significantly reduced in fluoxetine pretreated as compared to control group.</li>\u0000 \u0000 <li>Fluoxetine blocks the neuromuscular transmission and increases the potency of rocuronium-induced neuromuscular block.</li>\u0000 </ol>\u0000 \u0000 </div>","PeriodicalId":100151,"journal":{"name":"Autonomic and Autacoid Pharmacology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2013-03-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1111/aap.12005","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"31282095","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
H. Özyurt Bayraktar, H. Yananlı, B. Terzioğlu, Ş. Oktay, M. Kaleli, M. Z. Gören
{"title":"The role of NO in the posterior hypothalamus in amygdala-generated pressor responses in conscious rats","authors":"H. Özyurt Bayraktar, H. Yananlı, B. Terzioğlu, Ş. Oktay, M. Kaleli, M. Z. Gören","doi":"10.1111/aap.12004","DOIUrl":"10.1111/aap.12004","url":null,"abstract":"<div>\u0000 \u0000 <p>\u0000 \u0000 </p><ol>\u0000 \u0000 <li>The nitrergic system modulates cardiovascular functions of the central nucleus of amygdala (CeA) and the posterior hypothalamus (PH) which are involved in the central regulation of the cardiovascular system. The aim of this study was to investigate the contribution of nitric oxide (NO) in the PH in eliciting cardiovascular responses produced through electrical stimulation (ES) of the CeA. Rats were implanted with a stimulation electrode and a parenchymal cannula system into the CeA and a parenchymal cannula or a microdialysis probe into the PH. The next day, the femoral artery was cannulated for haemodynamic measurement. The CeA was electrically stimulated to produce cardiovascular response. The nitric oxide synthetase inhibitor, NG-nitro-L-arginine methyl ester (L-NAME; 400 nmol/100 nl) or artificial cerebrospinal fluid were injected into the PH or the CeA before the ES of the CeA. The dialysates were collected from the PH to determine the L-citrulline and the L-glutamic acid levels.</li>\u0000 \u0000 <li>L-NAME injection into the CeA but not to the PH suppressed the increases in the mean arterial pressure produced by the ES of the CeA significantly; however, heart rate was not affected by L-NAME injection into either the PH or the CeA. L-citrulline and L-glutamic acid levels in the PH were shown to be increased by the ES of the CeA.</li>\u0000 \u0000 <li>NO is involved between the PH and the CeA which has a considerable role in the central regulation of the cardiovascular system.</li>\u0000 </ol>\u0000 \u0000 </div>","PeriodicalId":100151,"journal":{"name":"Autonomic and Autacoid Pharmacology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2013-03-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1111/aap.12004","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"31374338","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}